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of people reported any kind of loss of workforce participation due to illnesses/
treatments. Average work loss productivity was significantly higher in females 
vs males (16% vs 13%, p< 0.05) and decreased with increase in age (20%, 17%, 
14%, 11% and 7% in 18-29, 30-39, 40-49, 50-64 and > 64 years old, respectively, 
p-value < 0.05). ConClusions: HRPQ has good construct and criterion validity. 
Presenteeism remains higher for paid work, while absenteeism remains higher 
for unpaid work.
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objeCtives: ASCEND is a phase 3, randomized, double-blind, placebo-controlled 
trial assessing whether natalizumab slows disability progression in secondary 
progressive multiple sclerosis (SPMS) patients. The aim of this current analysis 
was to use Rasch Measurement Theory (RMT) methods to evaluate the ABILHAND 
(56 item version), a PRO assessing manual ability, in SPMS patients, and to explore 
an optimized scoring structure based on empirical post-hoc analyses. Methods: 
Baseline blinded data from the 889 randomized patients in ASCEND were ana-
lyzed. In stage 1, RMT methods examined: scale-to-sample targeting, item fit, local 
dependency, and reliability. In stage 2, a post-hoc revision of the ABILHAND-56 
scoring structure and conceptual grouping of items was conducted and re-
evaluated using the same RMT methods. Results: Stage 1 analyses showed 
adequate scale performance: minor item misfit (2/56); minimal dependency (4 
pairs of items); good reliability (Person Separation Index = 0.93). However, there 
was ABILHAND-to-ASCEND sample mis-targeting (person location range [mean]: 
-7.31 to 1.83 [-3.62]; item location range [mean]: -5.75 to 4.27 [0.00]). In stage 2, all 
items were rescored on a dichotomous response scale (easy & difficult/impos-
sible) in an attempt to improve targeting. Also, the 56 items were re-categorized 
into two conceptually clearer manual ability sub-scales: ‘fine motor skills’ and 
‘power’. These ABILHAND-56 revisions improved targeting: ‘fine motor skills’ 
(person range [mean]: -5.39 to 5.34 [-1.75]; item range [mean]: -4.15 to 3.54 [0.00]), 
‘power’ (person range [mean]: -4.47 to 4.38 [-1.72]; item range [mean]: -4.15 to 
3.54 [0.00]). Sample measurement and item fit were consistent with the original 
ABILHAND-56. ConClusions: The ABILHAND-56 revised scoring demonstrated 
improved psychometric performance and provides an initial evidence-base for 
the enhancement of ABILHAND-56’s measurement performance in people with 
SPMS. Additional research will determine whether the two sub-scale structure 
of the revised ABILHAND-56 provides better interpretability of patient-reported 
manual ability.
PRM84
VaLidation oF the dePRession and FaMiLy Functioning scaLe (dFFs)
Francois C.1, Danchenko N.2, Williams V.3, Nelsen L.3, Williams N.J.3, Yarr S.4,  
DiBenedetti D.B.3, Lancon C.5
1Lundbeck LLC, Deerfield, IL, USA, 2Lundbeck S.A.S. Paris Fr, EU, Paris, France, 3RTI Health 
Solutions, Research Triangle Park, NC, USA, 4The Pavilion, Manchester, UK, 5Hospital Sainte-
Marguerite, Marseille, France
objeCtives: Patient-reported outcomes (PROs) are necessary to assess dis-
ease impacts from the patient’s perspective. In line with the Food and Drug 
Administration’s (FDA’s) guidance on PROs, the Depression and Family Functioning 
Scale (DFFS) was developed to assess the impact of major depressive disorder 
(MDD) on family functioning. Psychometric analyses were conducted to establish 
the reliability, validity, and responsiveness of the DFFS according to the FDA PRO 
guidance. Methods: Data from PERFORM, a longitudinal multicenter, prospec-
tive, 2-year observational study in the United Kingdom and Spain, were analyzed 
(NBaseline= 478; NMonth2= 433). The 15 DFFS items use a 5-point rating scale to 
assess partner and family interactions and quality of relationships; higher scores 
indicate greater (worse) impacts. Test-retest reliability (intraclass correlations), con-
struct validity (correlations and factor analysis), discriminating ability (analyses 
of variance), and responsiveness (effect size estimates) were evaluated. Results: 
Factor analyses resulted in a single factor, confirmed by highly satisfactory 
Cronbach’s alphas (0.85 at baseline, 0.89 at month 2). The DFFS demonstrated sat-
isfactory test-retest reliability (intraclass correlation= 0.75). Hypothesized correla-
tions with other measures provided evidence of convergent and divergent validity. 
For example, the correlation of the DFFS with SF-12 mental component scores was 
−0.35 (baseline) −0.49 (month 2), and with SF-12 physical component scores, −0.05 
(baseline) and −0.31 (month 2). Hypothesis tests were generally in the predicted 
direction and many were statistically significant, substantiating the discriminating 
ability of the DFFS. Effect size estimates of responsiveness were 0.44–0.84, dem-
onstrating that the items were capable of detecting change. ConClusions: The 
psychometric analyses strongly support the reliability, validity, and responsiveness 
of the DFFS and its usefulness for assessing the impacts of depression on family 
functioning. It has the potential to provide important information not traditionally 
captured in clinical practice or research and will facilitate a more comprehensive 
evaluation of treatments of MDD.
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objeCtives: We systematically investigate random utility maximization and 
random regret minimization modeling approaches to establish the impact of dif-
objeCtives: Hemophilia is a chronic disease typically diagnosed in infancy, char-
acterized by bleeding requiring regular or episodic infusion of clotting factor. Taking 
care of a child with hemophilia (CWH) may cause burden for caregivers. We aimed 
to develop a first “Hemophilia associated Caregiver Burden Scale” (HEMOCABTM) 
assessing the burden of hemophilia for caregivers of CWH. Methods: 
Questionnaire development included: 1) item generation (two semi-structured 
focus groups with 11 caregivers, evaluation of existing caregiver burden scales for 
relevance by 16 HCPs); 2) feasibility testing (cognitive interviews with 12 caregivers) 
and 3) pilot-testing (psychometric analysis of HEMOCABTM). Results: Item gen-
eration resulted in a preliminary version of HEMOCABTM consisting of 109 items. 
During feasibility testing, mean completion time was 19.3±6.3 minutes, some prob-
lems were revealed concerning item formulation, applicability of items for young 
children and missing items. The revised HEMOCABTM contained 108 questions 
grouped in 13 domains. HEMOCABTM was pilot-tested in 40 caregivers of CWH 
with a mean age of 39.32±8.9. The majority of CWH had hemophilia A (95%), were 
severely affected by hemophilia (77.5%) and 15% had inhibitors. Reliability estima-
tion showed high internal consistency of total score with Cronbach’s α = .97, and 
for 2 summary scores ‘FREQUENCY’ with α = .95 and ‘BURDEN’ α = .92; Cronbach’s α 
for the sub domains ranged from α = .77 to .93. HEMOCABTM revealed good conver-
gent validity with Impact on Family Scale (r= -.867 for total score). Known groups 
validity showed significant differences in all domains of HEMOCABTM, except for 
‘school’ among caregivers of CWH with inhibitors vs. without. Type of treatment 
and disease severity showed some differences between groups. Based on item and 
scale analysis 49 items were deleted and the final HEMOCABTM consists of 59 
items. ConClusions: HEMOCABTM is the first hemophilia-specific instrument for 
the assessment of caregiver burden and revealed good psychometric characteristics 
in terms of reliability and validity.
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objeCtives: Symptoms and physical limitations can have an important impact on 
the day to day lives of heart failure patients. The Clinical Summary Score (CSS) of 
the Kansas City Cardiomyopathy Questionnaire (KCCQ), a patient-reported outcome 
instrument, provides a measure of symptoms and physical limitations associated 
with heart failure. The primary goal of this study was to evaluate the psychometric 
properties of the CSS and its utility as an endpoint in clinical trials. Methods: 
Data from 3 randomized, controlled clinical trials with heart failure patients were 
included in analysis (ALOFT, PARAMOUNT, and PARADIGM trials). Studies were 
examined independently; within each study, data were collapsed across treat-
ment groups. Study measures included the KCCQ, physician-rated New York Heart 
Association (NYHA) classification, patient global impression of change (PGIC), and/
or NT-proBNP assay. Results: Findings were similar across the 3 trials. Mean CSS 
scores at baseline ranged from 63-76 (on a 0-100 scale, with higher scores indi-
cating better symptoms and physical functioning). Dimensionality assessments 
highlighted the complex nature of the scale, with evidence for first-, second-, and 
third-order factors. The CSS consistently discriminated between all four NYHA clas-
sifications (all pairwise comparisons p< .05). Correlations with BNP and NT-proBNP 
levels were statistically significant, but relatively small (-.12 and -.17 respectively). 
The CSS was sensitive to changes in patient status over time, as indexed by changes 
in the NYHA classification and PGIC. The responder definition – the amount of 
change within an individual patient that would be considered clinically meaning-
ful - was in the range of 6 to 10 points, which is higher than what has been seen in 
studies of the KCCQ overall score. ConClusions: Data from multiple heart failure 
clinical trials confirm the psychometric characteristics of the CSS. This evidence 
supports the use of the CSS as an endpoint in clinical trials examining heart failure 
treatments.
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objeCtives: To validate the Health-Related Productivity Questionnaire (HRPQ), 
a new health-related productivity instrument, and estimate the US population 
norms by age and gender. Methods: An online survey was developed that con-
sisted of four components: the HRPQ; a screener to determine relevant disease 
conditions-related and health-state questions; validated instruments such as 
Work Productivity and Activity Impairment (WPAI) and EQ-5D; and socio-demo-
graphic questions. The survey was administered by a third-party company for 
a 6-week period. Weightings were calculated to allow extrapolation of results 
from the 10,000 respondents to achieve values representing the general United 
States population. Validation analysis included concurrent and criterion validity, 
construct validity with group difference, extreme group comparison and factor 
analysis. Mean, median, standard error, 25th and 75thpercentiles were calculated 
for absenteeism, presenteeism measures for employed and household work and 
stratified by age, gender, age and gender. Results: The HRPQ showed strong 
concurrent validity with WPAI (Pearson’s r≥ 0.6, p-value< 0.05). Correlations of total 
productivity at work and home from HRPQ with EQ-5D scores, were small to mod-
erate, r= 0.3-0.5 (p-value< 0.05) and aligned with direction of the hypothesis. Several 
group difference analyses showed positive results for HRPQ. Presenteeism items 
heavily loaded on one factor and absenteeism and scheduled hours items loaded 
on second factor. General population estimates for average percent lost produc-
tivity at work was 14%, (absenteeism= 4%, presenteeism= 10%) and for household 
activities was 28% (absenteeism= 18%, presenteeism= 10%). Furthermore, 17% 
